Skip to main content

Studying the Oncosuppressive Functions of PTENP1 as a ceRNA

  • Protocol
  • First Online:
Pseudogenes

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2324))

Abstract

PTENP1 is a processed pseudogene of the tumour suppressor phosphatase and tensin homolog deleted on chromosome 10 (PTEN). It functions posttranscriptionally to regulate PTEN by acting as a sponge for microRNAs that target PTEN. PTENP1 therefore functions as a competitive endogenous RNA (ceRNA), competing with PTEN for binding of microRNAs (miRNA) and thereby modulating PTEN cellular abundance. Studies of the overexpression of PTENP1 all confirm its oncosuppressive function to be mediated through the suppression of cell proliferation, induction of apoptosis, and inhibition of cell migration and invasion of cancer cells of differing types. These oncosuppressive functions are a direct consequence of miRNA binding by PTENP1 and the subsequent liberation of PTEN from miRNA induced suppression. In this chapter, we will focus initially on the description of a high efficiency transient transfection method to introduce and overexpress PTENP1 in the cell type of interest, followed by accurate methodologies to measure transfection efficiency by flow cytometry. We will then continue to describe two methods to analyze cell proliferation, namely the CCK-8 assay and Click-iT® EdU assay. Due to commonalities in the manifestation of the oncosuppressive effects of PTENP1, mediated through its role as a ceRNA, the methods presented in this chapter will have wide applicability to a variety of different cell types.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. An Y, Furber KL, Ji S (2017) Pseudogenes regulate parental gene expression via ceRNA network. J Cell Mol Med 21(1):185–192. https://doi.org/10.1111/jcmm.12952

    Article  CAS  PubMed  Google Scholar 

  2. Poliseno L (2012) Pseudogenes: newly discovered players in human cancer. Sci Signal 5(242):re5. https://doi.org/10.1126/scisignal.2002858

    Article  CAS  PubMed  Google Scholar 

  3. Hu X, Yang L, Mo YY (2018) Role of pseudogenes in tumorigenesis. Cancers (Basel) 10(8). https://doi.org/10.3390/cancers10080256

  4. Tang J, Ning R, Zeng B, Li Y (2016) Molecular evolution of PTEN pseudogenes in mammals. PLoS One 11(12):e0167851. https://doi.org/10.1371/journal.pone.0167851

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Li W, Yang W, Wang XJ (2013) Pseudogenes: pseudo or real functional elements? J Genet Genomics 40(4):171–177. https://doi.org/10.1016/j.jgg.2013.03.003

    Article  CAS  PubMed  Google Scholar 

  6. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP (2010) A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465(7301):1033–1038. https://doi.org/10.1038/nature09144

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Dahia PL, FitzGerald MG, Zhang X, Marsh DJ, Zheng Z, Pietsch T, von Deimling A, Haluska FG, Haber DA, Eng C (1998) A highly conserved processed PTEN pseudogene is located on chromosome band 9p21. Oncogene 16(18):2403–2406. https://doi.org/10.1038/sj.onc.1201762

    Article  CAS  PubMed  Google Scholar 

  8. Haddadi N, Lin Y, Travis G, Simpson AM, Nassif NT, McGowan EM (2018) PTEN/PTENP1: ‘Regulating the regulator of RTK-dependent PI3K/Akt signalling’, new targets for cancer therapy. Mol Cancer 17(1):37. https://doi.org/10.1186/s12943-018-0803-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Johnsson P, Ackley A, Vidarsdottir L, Lui WO, Corcoran M, Grander D, Morris KV (2013) A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. Nat Struct Mol Biol 20(4):440–446. https://doi.org/10.1038/nsmb.2516

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. He L (2010) Posttranscriptional regulation of PTEN dosage by noncoding RNAs. Sci Signal 3(146):pe39. https://doi.org/10.1126/scisignal.3146pe39

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Alimonti A, Carracedo A, Clohessy JG, Trotman LC, Nardella C, Egia A, Salmena L, Sampieri K, Haveman WJ, Brogi E, Richardson AL, Zhang J, Pandolfi PP (2010) Subtle variations in Pten dose determine cancer susceptibility. Nat Genet 42(5):454–458. https://doi.org/10.1038/ng.556

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Hollander MC, Blumenthal GM, Dennis PA (2011) PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat Rev Cancer 11(4):289–301. https://doi.org/10.1038/nrc3037

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Berger AH, Knudson AG, Pandolfi PP (2011) A continuum model for tumour suppression. Nature 476(7359):163–169. https://doi.org/10.1038/nature10275

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP (2011) A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146(3):353–358. https://doi.org/10.1016/j.cell.2011.07.014

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297. https://doi.org/10.1016/s0092-8674(04)00045-5

    Article  CAS  PubMed  Google Scholar 

  16. Karreth FA, Pandolfi PP (2013) ceRNA cross-talk in cancer: when ce-bling rivalries go awry. Cancer Discov 3(10):1113–1121. https://doi.org/10.1158/2159-8290.CD-13-0202

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Yu G, Yao W, Gumireddy K, Li A, Wang J, Xiao W, Chen K, Xiao H, Li H, Tang K, Ye Z, Huang Q, Xu H (2014) Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression. Mol Cancer Ther 13(12):3086–3097. https://doi.org/10.1158/1535-7163.MCT-14-0245

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Liu J, Xing Y, Xu L, Chen W, Cao W, Zhang C (2017) Decreased expression of pseudogene PTENP1 promotes malignant behaviours and is associated with the poor survival of patients with HNSCC. Sci Rep 7:41179. https://doi.org/10.1038/srep41179

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Zhang R, Guo Y, Ma Z, Ma G, Xue Q, Li F, Liu L (2017) Long non-coding RNA PTENP1 functions as a ceRNA to modulate PTEN level by decoying miR-106b and miR-93 in gastric cancer. Oncotarget 8(16):26079–26089. https://doi.org/10.18632/oncotarget.15317

    Article  PubMed  PubMed Central  Google Scholar 

  20. Hu S, Xu L, Li L, Luo D, Zhao H, Li D, Peng B (2019) Overexpression of lncRNA PTENP1 suppresses glioma cell proliferation and metastasis in vitro. Onco Targets Ther 12:147–156. https://doi.org/10.2147/OTT.S182537

    Article  CAS  PubMed  Google Scholar 

  21. Qian YY, Li K, Liu QY, Liu ZS (2017) Long non-coding RNA PTENP1 interacts with miR-193a-3p to suppress cell migration and invasion through the PTEN pathway in hepatocellular carcinoma. Oncotarget 8(64):107859–107869. https://doi.org/10.18632/oncotarget.22305

    Article  PubMed  PubMed Central  Google Scholar 

  22. Yu G, Ou ZY, Tao QY, Wan GY, Lu ZH, Lang B (2017) Role of lncRNA PTENP1 in tumorigenesis and progression of bladder cancer and the molecular mechanism. Nan Fang Yi Ke Da Xue Xue Bao 37(11):1494–1500

    CAS  PubMed  Google Scholar 

  23. Zheng R, Du M, Wang X, Xu W, Liang J, Wang W, Lv Q, Qin C, Chu H, Wang M, Yuan L, Qian J, Zhang Z (2018) Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression. Mol Cancer 17(1):143. https://doi.org/10.1186/s12943-018-0880-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Gao X, Qin T, Mao J, Zhang J, Fan S, Lu Y, Sun Z, Zhang Q, Song B, Li L (2019) PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway. J Exp Clin Cancer Res 38(1):256. https://doi.org/10.1186/s13046-019-1260-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Yndestad S, Austreid E, Skaftnesmo KO, Lonning PE, Eikesdal HP (2018) Divergent activity of the pseudogene PTENP1 in ER-positive and negative breast cancer. Mol Cancer Res 16(1):78–89. https://doi.org/10.1158/1541-7786.MCR-17-0207

    Article  CAS  PubMed  Google Scholar 

  26. Li RK, Gao J, Guo LH, Huang GQ, Luo WH (2017) PTENP1 acts as a ceRNA to regulate PTEN by sponging miR-19b and explores the biological role of PTENP1 in breast cancer. Cancer Gene Ther 24(7):309–315. https://doi.org/10.1038/cgt.2017.29

    Article  CAS  PubMed  Google Scholar 

  27. Shi X, Tang X, Su L (2018) Overexpression of long noncoding RNA PTENP1 inhibits cell proliferation and migration via suppression of miR-19b in breast cancer cells. Oncol Res 26(6):869–878. https://doi.org/10.3727/096504017X15123838050075

    Article  PubMed  PubMed Central  Google Scholar 

  28. Salic A, Mitchison TJ (2008) A chemical method for fast and sensitive detection of DNA synthesis in vivo. Proc Natl Acad Sci U S A 105(7):2415–2420. https://doi.org/10.1073/pnas.0712168105

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

Glena Travis is supported by the Australian Research Training Program Stipend Scholarship, and Nahal Haddadi was supported by a University of Technology Sydney International Research Scholarship.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Najah T. Nassif .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Travis, G., Haddadi, N., Simpson, A.M., Marsh, D.J., McGowan, E.M., Nassif, N.T. (2021). Studying the Oncosuppressive Functions of PTENP1 as a ceRNA . In: Poliseno, L. (eds) Pseudogenes. Methods in Molecular Biology, vol 2324. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1503-4_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-1503-4_11

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-1502-7

  • Online ISBN: 978-1-0716-1503-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics